Recommended Posts

New research has identified a biological ?trigger? for Parkinson?s disease. The findings, published in the journal Cell, may lead the way to early diagnostic tools and treatments that could shut down the disease before symptoms progress in patients.

Using both human neurons and fruit flies, researchers at Johns Hopkins have identified a protein, s15, that triggers a common form of Parkinson?s disease. The protein is enabled by an enzyme - leucine-rich repeat kinase 2 (LRRK2) - which then causes neurodegeneration.

Previous research has shown that mutations in LRRK2 are linked with neurodegeneration, and therefore, the progression of Parkinson?s disease. LRRK2 had been previously identified to be a protein kinase, which means it is a type of enzyme that adds phosphates on to other proteins and either turns proteins on or off or changes the protein?s activity. However, the proteins LRRK2 was acting on were unknown?until now.

?How mutations in [LRRK2] cause Parkinson?s disease aren?t well known, and what this study does is provides a pretty convincing set of data on how mutations in LRRK2 cause Parkinson?s disease,? study author Dr. Ted Dawson, professor of neurology and director of the Johns Hopkins Institute for Cell Engineering, told FoxNews.com.

The study?s findings suggest that inhibiting s15 and LRRK2 could prevent the loss of dopamine neurons and the onset of Parkinson?s disease. LRRK2 inhibitors exist, but have not been tested in patient trials. Studies are needed to identify inhibitors of s15, Dawson said.

Parkinson?s disease is a neurodegenerative disorder that affects nearly one million people in the U.S., according to the Parkinson?s Disease Foundation. With the disease, the brain loses dopamine-producing cells? dopamine sends messages to the brain control movement and coordination.

more

Link to comment
Share on other sites

This is fantastic news. Being able to diagnose and maybe even prevent Parkinson's is a huge leap forward for medicine.

I hope this research leads somewhere, because degenerative diseases are incredibly taxing on not only the patients, but their families as well. If these results lead to a breakthrough, it will help a lot of people.

  • Like 2
Link to comment
Share on other sites

This is fantastic news. Being able to diagnose and maybe even prevent Parkinson's is a huge leap forward for medicine.

I hope this research leads somewhere, because degenerative diseases are incredibly taxing on not only the patients, but their families as well. If these results lead to a breakthrough, it will help a lot of people.

 

also it costs the state allot of money (if your have health care state sponsored).

Link to comment
Share on other sites

This topic is now closed to further replies.